Important bacterial gastrointestinal pathogens in children: A pathogenesis perspective

Pediatric Clinics of North America

Volumn 52, Issue 3, 2005, Pages 749-777

  Amieva, Manuel R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; CLOTRIMAZOLE; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; PROTEIN INHIBITOR; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRANSMEMBRANE CONDUCTANCE REGULATOR INHIBITOR; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BLOOD CULTURE; CAMPYLOBACTER; CHILD; DIAGNOSTIC PROCEDURE; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FECES ANALYSIS; FLUID THERAPY; GASTRITIS; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION RATE; INTESTINE FLORA; NONHUMAN; PATHOGENICITY; PEPTIC ULCER; PREVALENCE; REVIEW; SALMONELLA; SALMONELLOSIS; SERODIAGNOSIS; SHIGELLA; SHIGELLOSIS; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH LYMPHOMA; SYMPTOMATOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CAMPYLOBACTER INFECTIONS; CELL ADHESION; CHILD; CHILD WELFARE; DEVELOPED COUNTRIES; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GASTROENTERITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; PEDIATRICS; SALMONELLA INFECTIONS;

EID: 19544374510     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.03.002     Document Type: Review

References (211)

1. B.J. Marshall The Campylobacter pylori story Scand J Gastroenterol Suppl 146 1988 58 66
2. B. Drumm, A. O'Brien, and E. Cutz Campylobacter pyloridis-associated primary gastritis in children Pediatrics 80 1987 192 195
3. E.J. Eastham, T.S. Elliott, and D. Berkeley Campylobacter pylori infection in children J Infect 16 1988 77 79
4. C. Imrie, M. Rowland, and B. Bourke Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 107 2001 373 380
5. S.R. Han, H.C. Zschausch, and H.G. Meyer Helicobacter pylori: clonal population structure and restricted transmission within families revealed by molecular typing J Clin Microbiol 38 2000 515 524
6. R.J. Owen, and J. Xerry Tracing clonality of Helicobacter pylori infecting family members from analysis of DNA sequences of three housekeeping genes (ureI, atpA and ahpC), deduced amino acid sequences, and pathogenicity-associated markers (cagA and vacA) J Med Microbiol 52 2003 3646 3651
7. D. Falush, T. Wirth, and B. Linz Traces of human migrations in Helicobacter pylori populations Science 299 2003 1582 1585
8. M. Deltenre, and E. de Koster How come I've got it? (A review of Helicobacter pylori transmission) Eur J Gastroenterol Hepatol 12 2000 479 482
9. K.J. Goodman, and P. Correa Transmission of Helicobacter pylori among siblings Lancet 355 2000 358 362
10. H. Miyaji, T. Azuma, and S. Ito Helicobacter pylori infection occurs via close contact with infected individuals in early childhood J Gastroenterol Hepatol 15 2000 257 262
11. H.M. Malaty, A. El-Kasabany, and D.Y. Graham Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood Lancet 359 2002 931 935
12. P. Lindkvist, D. Asrat, and I. Nilsson Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country Scand J Infect Dis 28 1996 181 184
13. D.J. Kelly The physiology and metabolism of the human gastric pathogen Helicobacter pylori Adv Microb Physiol 40 1998 3529 3539
14. D.S. Merrell, M.L. Goodrich, and G. Otto pH-regulated gene expression of the gastric pathogen Helicobacter pylori Infect Immun 71 2003 137 189
15. S. Foynes, N. Dorrell, and S.J. Ward Helicobacter pylori possesses two CheY response regulators and a histidine kinase sensor, CheA, which are essential for chemotaxis and colonization of the gastric mucosa Infect Immun 68 2000 2016 2023
16. A. Lee The microbiology and epidemiology of Helicobacter pylori infection Scand J Gastroenterol Suppl 201 1994 2 6
17. L. Thomsen, C. Tasman-Jones, and A. Morris Ammonia produced by Campylobacter pylori neutralizes H+ moving through gastric mucus Scand J Gastroenterol 24 1989 761 768
18. M. Eltumi, M.J. Brueton, and N. Francis Diagnosis of Helicobacter pylori gastritis in children using the 13C urea breath test J Clin Gastroenterol 28 1999 238 240
19. J.L. Kazi, R. Sinniah, and V. Zaman Ultrastructural study of Helicobacter pylori-associated gastritis J Pathol 161 1990 65 70
20. T. Wadstrom, S. Hirmo, and B. Nilsson Biochemical aspects of H. pylori adhesion J Physiol Pharmacol 48 1997 325 331
21. S. Backert, E. Ziska, and V. Brinkmann Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus Cell Microbiol 2 2000 155 164
22. S. Odenbreit, J. Puls, and B. Sedlmaier Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion Science 287 2000 1497 1500
23. M. Stein, R. Rappuoli, and A. Covacci Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation Proc Natl Acad Sci U S A 97 2000 1263 1268
24. S. Censini, M. Stein, and A. Covacci Cellular responses induced after contact with Helicobacter pylori Curr Opin Microbiol 4 2001 41 46
25. Y. Churin, L. Al-Ghoul, and O. Kepp Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response J Cell Biol 161 2003 249 255
26. H. Higashi, R. Tsutsumi, and S. Muto SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein Science 295 2002 683 686
27. M. Stein, F. Bagnoli, and R. Halenbeck c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs Mol Microbiol 43 2002 971 980
28. M.R. Amieva, R. Vogelmann, and A. Covacci Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA Science 300 2003 1430 1434
29. M. Camorlinga-Ponce, C. Romo, and G. Gonzalez-Valencia Topographical localisation of cagA positive and cagA negative Helicobacter pylori strains in the gastric mucosa:an in situ hybridisation study J Clin Pathol 57 2004 822 828
30. S.L. Hazell, A. Lee, and L. Brady Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium J Infect Dis 153 1986 658 663
31. L.A. Noach, T.M. Rolf, and G.N. Tytgat Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa J Clin Pathol 47 1994 699 704
32. A.M. Terres, J.M. Pajares, and A.M. Hopkins Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators Infect Immun 66 1998 2943 2950
33. K. van Amsterdam, and A. van der Ende Nutrients released by gastric epithelial cells enhance Helicobacter pylori growth Helicobacter 9 2004 614 621
34. Y. Yamashiro, S. Oguchi, and Y. Otsuka Helicobacter pylori colonization in children with gastritis and peptic ulcer: II. ultrastructural change of the gastric mucosa Acta Paediatr Jpn 36 1994 171 175
35. M.R. Amieva, N.R. Salama, and L.S. Tompkins Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells Cell Microbiol 4 2002 677 690
36. K. Hulten, O. Cars, and E. Hjelm In-vitro activity of azithromycin in against intracellular Helicobacter pylori J Antimicrob Chemother 37 1996 483 489
37. G.H. Ko, S.M. Kang, and Y.K. Kim Invasiveness of Helicobacter pylori into human gastric mucosa Helicobacter 4 1999 77 81
38. F.A. Wyle, A. Tarnawski, and D. Schulman Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study J Clin Gastroenterol 12 Suppl 1 1990 S92 S98
39. M. de Bernard, A. Cappon, and G. Del Giudice The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori Int J Med Microbiol 293 2004 589 597
40. J.A. Nowak, and B. Forouzandeh Estimates of Helicobacter pylori densities in the gastric mucus layer by PCR, histologic examination, and CLOtest Am J Clin Pathol 108 1997 284 288
41. M. Ashorn What are the specific features of Helicobacter pylori gastritis in children? Ann Med 27 1995 617 620
42. S.M. Gormally, N. Prakash, and M.T. Durnin Association of symptoms with Helicobacter pylori infection in children J Pediatr 126 1995 753 756
43. A. Kimia, I. Zahavi, and R. Shapiro The role of Helicobacter pylori and gastritis in children with recurrent abdominal pain Isr Med Assoc J 2 2000 126 128
44. J. Kokkonen, M. Haapalahti, and S. Tikkanen Gastrointestinal complaints and diagnosis in children: a population-based study Acta Paediatr 93 2004 880 886
45. S.K. Mittal, and J.L. Mathew Helicobacter pylori infection in children: a review Trop Gastroenterol 24 2003 106 115
46. G. Prieto, I. Polanco, and J. Larrauri Helicobacter pylori infection in children: clinical, endoscopic, and histologic correlations J Pediatr Gastroenterol Nutr 14 1992 420 425
47. V. Tolia Helicobacter pylori infection in pediatric patients Curr Gastroenterol Rep 1 1999 308 313
48. S. Kato, Y. Nishino, and K. Ozawa The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease J Gastroenterol 39 2004 734 738
49. C. Macarthur, N. Saunders, and W. Feldman Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children JAMA 273 1995 729 734
50. M. Ashorn, T. Ruuska, and R. Karikoski Helicobacter pylori gastritis in dyspeptic children: a long-term follow-up after treatment with colloidal bismuth subcitrate and tinidazole Scand J Gastroenterol 29 1994 203 208
51. C. De Giacomo, V. Valdambrini, and F. Lizzoli A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents Helicobacter 7 2002 356 363
52. A.A. Gunaid, N.A. Hassan, and I. Murray-Lyon Prevalence and risk factors for Helicobacter pylori infection among Yemeni dyspeptic patients Saudi Med J 24 2003 512 517
53. J.S. Hyams, P. Davis, and F.A. Sylvester Dyspepsia in children and adolescents: a prospective study J Pediatr Gastroenterol Nutr 30 2000 413 418
54. P.M. Sherman, and C. Macarthur Current controversies associated with Helicobacter pylori infection in the pediatric population Front Biosci 6 2001 E187 E192
55. K. Ando, T. Shimamoto, and T. Tauchi Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review Int J Hematol 77 2003 239 244
56. M. Franchini, and D. Veneri Helicobacter pylori infection and immune thrombocytopenic purpura: an update Helicobacter 9 2004 342 346
57. M.R. Huber, S. Kumar, and A. Tefferi Treatment advances in adult immune thrombocytopenic purpura Ann Hematol 82 2003 723 737
58. A.E. Kurekci, A.A. Atay, and S.U. Sarici Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report Pediatr Hematol Oncol 21 2004 593 596
59. M. Michel, N. Cooper, and C. Jean Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 103 2004 890 896
60. T. Takahashi, T. Yujiri, and K. Shinohara Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura Br J Haematol 124 2004 91 96
61. M. Ashorn, T. Ruuska, and A. Makipernaa Helicobacter pylori and iron deficiency anaemia in children Scand J Gastroenterol 36 2001 701 705
62. T. Takahashi, T. Yujiri, and Y. Tanizawa Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains Blood 104 2004 594
63. A. Barabino, C. Dufour, and C.E. Marino Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence J Pediatr Gastroenterol Nutr 28 1999 116 119
64. Y.H. Choe, S.K. Kim, and Y.C. Hong The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children Arch Dis Child 88 2003 178
65. J.W. Choi Does Helicobacter pylori infection relate to iron deficiency anaemia in prepubescent children under 12 years of age? Acta Paediatr 92 2003 970 972
66. J.K. Seo, J.S. Ko, and K.D. Choi Serum ferritin and Helicobacter pylori infection in children: a sero-epidemiologic study in Korea J Gastroenterol Hepatol 17 2002 754 757
67. A. Aggarwal Helicobacter pylori infection: a cause of growth delay in children Indian Pediatr 35 1998 191 192
68. L.E. Bravo, R. Mera, and J.C. Reina Impact of Helicobacter pylori infection on growth of children: a prospective cohort study J Pediatr Gastroenterol Nutr 37 2003 614 619
69. D. Ertem, and E. Pehlivanoglu Helicobacter pylori may influence height in children independent of socioeconomic factors J Pediatr Gastroenterol Nutr 35 2002 232 233
70. G. Oderda, D. Palli, and C. Saieva Short stature and Helicobacter pylori infection in Italian children: prospective multicentre hospital based case-control study. The Italian Study Group on Short Stature and H pylori BMJ 317 1998 514 515
71. T. Richter, S. List, and D.M. Muller Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children J Pediatr Gastroenterol Nutr 33 2001 472 475
72. J. Clemens, M.J. Albert, and M. Rao Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera J Infect Dis 171 1995 1653 1656
73. H. Shmuely, Z. Samra, and S. Ashkenazi Association of Helicobacter pylori infection with Shigella gastroenteritis in young children Am J Gastroenterol 99 2004 2041 2045
74. M.K. Bhan, R. Bahl, and S. Sazawal Association between Helicobacter pylori infection and increased risk of typhoid fever J Infect Dis 186 2002 1857 1860
75. M. Okuda, E. Miyashiro, and M. Koike Serodiagnosis of Helicobacter pylori infection is not accurate for children aged below 10 Pediatr Int 44 2002 387 390
76. S. Kato, K. Ozawa, and M. Okuda Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection: a multicenter Japanese study Am J Gastroenterol 98 2003 296 300
77. B.D. Gold, R.B. Colletti, and M. Abbott Helicobacter pylori infection in children: recommendations for diagnosis and treatment J Pediatr Gastroenterol Nutr 31 2000 490 497
78. P. Malfertheiner, F. Megraud, and C. O'Morain Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report Aliment Pharmacol Ther 16 2002 167 180
79. P. Sherman, E. Hassall, and R.H. Hunt Canadian Helicobacter Study Group Consensus Conference on the approach to Helicobacter pylori infection in children and adolescents Can J Gastroenterol 13 1999 553 559
80. F. Gottrand, N. Kalach, and C. Spyckerelle Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial J Pediatr 139 2001 664 668
81. S. Kato, M. Konno, and S. Maisawa Results of triple eradication therapy in Japanese children: a retrospective multicenter study J Gastroenterol 39 2004 838 843
82. M. Rowland, D. Kumar, and L. Daly Low rates of Helicobacter pylori reinfection in children Gastroenterology 117 1999 336 341
83. A.E. Wold, D.A. Caugant, and G. Lidin-Janson Resident colonic Escherichia coli strains frequently display uropathogenic characteristics J Infect Dis 165 1992 46 52
84. S.P. Bonacorsi, O. Clermont, and C. Tinsley Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains Infect Immun 68 2000 2096 2101
85. N.V. Prasadarao, C.A. Wass, and K.S. Kim Identification and characterization of S fimbria-binding sialoglycoproteins on brain microvascular endothelial cells Infect Immun 65 1997 2852 2860
86. J.B. Kaper, J.P. Nataro, and H.L. Mobley Pathogenic Escherichia coli Nat Rev Microbiol 2 2004 123 140
87. R.E. Black, M.H. Merson, and I. Huq Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh: implications for vaccine development Lancet 1 1981 141 143
88. E.C. Todd Epidemiology of foodborne diseases: a worldwide review World Health Stat Q 50 1997 30 50
89. W. Gaastra, and A.M. Svennerholm Colonization factors of human enterotoxigenic Escherichia coli (ETEC) Trends Microbiol 4 1996 444 452
90. J.P. Nataro, and J.B. Kaper Diarrheagenic Escherichia coli Clin Microbiol Rev 11 1998 142 201
91. F. Albano, T. Brasitus, and E.A. Mann Colonocyte basolateral membranes contain Escherichia coli heat-stable enterotoxin receptors Biochem Biophys Res Commun 284 2001 331 334
92. A.B. Vaandrager Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C Mol Cell Biochem 230 2002 73 83
93. J.R. Thiagarajah, and A.S. Verkman CFTR pharmacology and its role in intestinal fluid secretion Curr Opin Pharmacol 3 2003 594 599
94. S.E. Gabriel, K.N. Brigman, and B.H. Koller Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model Science 266 1994 107 109
95. H. Fischer, T.E. Machen, and J.H. Widdicombe A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells J Ethnopharmacol 93 2004 351 357
96. T. Ma, J.R. Thiagarajah, and H. Yang Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion J Clin Invest 110 2002 1651 1658
97. N.D. Sonawane, C. Muanprasat, and R. Nagatani Jr In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents J Pharm Sci 94 2004 134 143
98. J.R. Thiagarajah, T. Broadbent, and E. Hsieh Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor Gastroenterology 126 2004 511 519
99. S.M. Hill, A.D. Phillips, and J.A. Walker-Smith Enteropathogenic Escherichia coli and life threatening chronic diarrhoea Gut 32 1991 154 158
100. J.P. Nougayrede, P.J. Fernandes, and M.S. Donnenberg Adhesion of enteropathogenic Escherichia coli to host cells Cell Microbiol 5 2003 359 372
101. R. DeVinney, A. Gauthier, and A. Abe Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells Cell Mol Life Sci 55 1999 961 976
102. S.C. Clarke, R.D. Haigh, and P.P. Freestone Virulence of enteropathogenic Escherichia coli, a global pathogen Clin Microbiol Rev 16 2003 365 378
103. B.A. Vallance, and B.B. Finlay Exploitation of host cells by enteropathogenic Escherichia coli Proc Natl Acad Sci U S A 97 2000 8799 8806
104. P. Dean, and B. Kenny Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein Mol Microbiol 54 2004 665 675
105. M.K. Bhan, V. Khoshoo, and H. Sommerfelt Enteroaggregative Escherichia coli and Salmonella associated with nondysenteric persistent diarrhea Pediatr Infect Dis J 8 1989 499 502
106. M.K. Bhan, P. Raj, and M.M. Levine Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India J Infect Dis 159 1989 1061 1064
107. S. Knutton, R.K. Shaw, and M.K. Bhan Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa Infect Immun 60 1992 2083 2091
108. Y. Nishikawa, Z. Zhou, and A. Hase Diarrheagenic Escherichia coli isolated from stools of sporadic cases of diarrheal illness in Osaka City, Japan between 1997 and 2000: prevalence of enteroaggregative E. coli heat-stable enterotoxin 1 gene-possessing E. coli Jpn J Infect Dis 55 2002 183 190
109. W.L. Pabst, M. Altwegg, and C. Kind Prevalence of enteroaggregative Escherichia coli among children with and without diarrhea in Switzerland J Clin Microbiol 41 2003 2289 2293
110. J. Sarantuya, J. Nishi, and N. Wakimoto Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children J Clin Microbiol 42 2004 133 139
111. A. Canizalez-Roman, and F. Navarro-Garcia Fodrin CaM-binding domain cleavage by Pet from enteroaggregative Escherichia coli leads to actin cytoskeletal disruption Mol Microbiol 48 2003 947 958
112. F. Navarro-Garcia, A. Canizalez-Roman, and J. Luna Plasmid-encoded toxin of enteroaggregative Escherichia coli is internalized by epithelial cells Infect Immun 69 2001 1053 1060
113. S.M. Ostroff, J.M. Kobayashi, and J.H. Lewis Infections with Escherichia coli O157:H7 in Washington State: the first year of statewide disease surveillance JAMA 262 1989 355 359
114. J. Garmendia, A.D. Phillips, and M.F. Carlier TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton Cell Microbiol 6 2004 1167 1183
115. A.W. Friedrich, M. Bielaszewska, and W.L. Zhang Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms J Infect Dis 185 2002 74 84
116. D. Werber, A. Fruth, and U. Buchholz Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome Eur J Clin Microbiol Infect Dis 22 2003 726 730
117. K. Sandvig Shiga toxins Toxicon 39 2001 1629 1635
118. T. Waddell, S. Head, and M. Petric Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2 Biochem Biophys Res Commun 152 1988 674 679
119. R.S. Heyderman, M. Soriani, and T.R. Hirst Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS? Trends Microbiol 9 2001 262 266
120. V.L. Tesh, B. Ramegowda, and J.E. Samuel Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages Infect Immun 62 1994 5085 5094
121. C.M. Thorpe, W.E. Smith, and B.P. Hurley Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression Infect Immun 69 2001 6140 6147
122. P.K. Stricklett, A.K. Hughes, and Z. Ergonul Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression J Infect Dis 186 2002 976 982
123. U. Fagundes-Neto, E. Freymuller, and L. Gandolfi Schimitz Nutritional impact and ultrastructural intestinal alterations in severe infections due to enteropathogenic Escherichia coli strains in infants J Am Coll Nutr 15 1996 180 185
124. U. Fagundes-Neto, and I.C. Scaletsky The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition Sao Paulo Med J 118 2000 21 29
125. C. Zoja, M. Morigi, and G. Remuzzi The role of the endothelium in hemolytic uremic syndrome J Nephrol 14 Suppl 4 2001 S58 S62
126. D. Tapper, P. Tarr, and E. Avner Lessons learned in the management of hemolytic uremic syndrome in children J Pediatr Surg 30 1995 158 163
127. K. Yoshioka, K. Yagi, and N. Moriguchi Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996 Pediatr Int 41 1999 223 227
128. R.E. Begue, D.I. Mehta, and U. Blecker Escherichia coli and the hemolytic-uremic syndrome South Med J 91 1998 798 804
129. Z. Dolezel, L. Kopecna, and J. Starha Is it possible to influence the mortality in children with hemolytic uremic syndrome? Bratisl Lek Listy 102 2001 59 65
130. D. Senerwa, L.N. Mutanda, and J.M. Gathuma Antimicrobial resistance of enteropathogenic Escherichia coli strains from a nosocomial outbreak in Kenya APMIS 99 1991 728 734
131. A. Thoren Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics Acta Pathol Microbiol Scand [B] 88 1980 265 268
132. C. Welinder-Olsson, E. Kjellin, and M. Badenfors Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection Eur J Clin Microbiol Infect Dis 19 2000 843 851
133. C.M. Thorpe Shiga toxin-producing Escherichia coli infection Clin Infect Dis 38 2004 1298 1303
134. B.P. Bell, P.M. Griffin, and P. Lozano Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections Pediatrics 100 1997 E12
135. N. Cimolai, S. Basalyga, and D.G. Mah A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome Clin Nephrol 42 1994 85 89
136. F. Proulx, J.P. Turgeon, and G. Delage Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis J Pediatr 121 1992 299 303
137. K. Ikeda, O. Ida, and K. Kimoto Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection Clin Nephrol 52 1999 357 362
138. S. Dundas, W.T. Todd, and A.I. Stewart The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients Clin Infect Dis 33 2001 923 931
139. C.S. Wong, S. Jelacic, and R.L. Habeeb The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections N Engl J Med 342 2000 1930 1936
140. X. Zhang, A.D. McDaniel, and L.E. Wolf Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice J Infect Dis 181 2000 664 670
141. A.W. Paton, R. Morona, and J.C. Paton A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans Nat Med 6 2000 265 270
142. M. Watanabe, K. Matsuoka, and E. Kita Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections J Infect Dis 189 2004 360 368
143. H. Trachtman, A. Cnaan, and E. Christen Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial JAMA 290 2003 1337 1344
144. S. Tzipori, A. Sheoran, and D. Akiyoshi Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome Clin Microbiol Rev 17 2004 926 941
145. O.S. Levine, and M.M. Levine Houseflies (Musca domestica) as mechanical vectors of shigellosis Rev Infect Dis 13 1991 688 696
146. P.J. Sansonetti, and A. Phalipon M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process Semin Immunol 11 1999 193 203
147. G. Tran Van Nhieu, R. Bourdet-Sicard, and G. Dumenil Bacterial signals and cell responses during Shigella entry into epithelial cells Cell Microbiol 2 2000 187 193
148. N. High, J. Mounier, and M.C. Prevost IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole EMBO J 11 1992 1991 1999
149. M.B. Goldberg, and J.A. Theriot Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility Proc Natl Acad Sci U S A 92 1995 6572 6576
150. W.C. Huskins, J.K. Griffiths, and A.S. Faruque Shigellosis in neonates and young infants J Pediatr 125 1994 14 22
151. M.L. Replogle, D.W. Fleming, and P.R. Cieslak Emergence of antimicrobial-resistant shigellosis in Oregon Clin Infect Dis 30 2000 515 519
152. S. Ashkenazi, J. Amir, and Y. Waisman A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis J Pediatr 123 1993 817 821
153. T. Eidlitz-Marcus, Y.H. Cohen, and M. Nussinovitch Comparative efficacy of two- and five-day courses of ceftriaxone for treatment of severe shigellosis in children J Pediatr 123 1993 822 824
154. W. Basualdo, and A. Arbo Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children Pediatr Infect Dis J 22 2003 374 377
155. S.K. Bhattacharya, and D. Sur An evaluation of current shigellosis treatment Expert Opin Pharmacother 4 2003 1315 1320
156. W.A. Khan, C. Seas, and U. Dhar Treatment of shigellosis: V. comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial Ann Intern Med 126 1997 697 703
157. K. Chan, S. Baker, and C.C. Kim Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S. enterica serovar typhimurium DNA microarray J Bacteriol 185 2003 553 563
158. S. Porwollik, E.F. Boyd, and C. Choy Characterization of Salmonella enterica subspecies I genovars by use of microarrays J Bacteriol 186 2004 5883 5898
159. J. De Buck, F. Van Immerseel, and F. Haesebrouck Colonization of the chicken reproductive tract and egg contamination by Salmonella J Appl Microbiol 97 2004 233 245
160. R. Davies, and M. Breslin Environmental contamination and detection of Salmonella enterica serovar enteritidis in laying flocks Vet Rec 149 2001 699 704
161. R.H. Davies, and C. Wray Mice as carriers of Salmonella enteritidis on persistently infected poultry units Vet Rec 137 1995 337 341
162. H.L. Shivaprasad, J.F. Timoney, and S. Morales Pathogenesis of Salmonella enteritidis infection in laying chickens: I. studies on egg transmission, clinical signs, fecal shedding, and serologic responses Avian Dis 34 1990 548 557
163. J.F. Timoney, H.L. Shivaprasad, and R.C. Baker Egg transmission after infection of hens with Salmonella enteritidis phage type 4 Vet Rec 125 1989 600 601
164. D.J. Vugia, M. Samuel, and M.M. Farley Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome Clin Infect Dis 38 Suppl 3 2004 S149 S156
165. P. Holt Severe salmonella infection in patients with reduced gastric acidity Practitioner 229 1985 1027 1030
166. S.N. Khosla, N. Jain, and A. Khosla Gastric acid secretion in typhoid fever Postgrad Med J 69 1993 121 123
167. M.R. Neutra, and J.P. Kraehenbuhl The role of transepithelial transport by M cells in microbial invasion and host defense J Cell Sci Suppl 17 1993 209 215
168. K.L. Penheiter, N. Mathur, and D. Giles Non-invasive Salmonella typhimurium mutants are avirulent because of an inability to enter and destroy M cells of ileal Peyer's patches Mol Microbiol 24 1997 697 709
169. K. Hueffer, and J.E. Galan Salmonella-induced macrophage death: multiple mechanisms, different outcomes Cell Microbiol 6 2004 1019 1025
170. D.M. Monack, D.M. Bouley, and S. Falkow Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1 + / + mice and can be reactivated by IFNgamma neutralization J Exp Med 199 2004 231 241
171. D.M. Monack, A. Mueller, and S. Falkow Persistent bacterial infections: the interface of the pathogen and the host immune system Nat Rev Microbiol 2 2004 747 765
172. S. Devi, and C.J. Murray Salmonella carriage rate amongst school children-a three year study Southeast Asian J Trop Med Public Health 22 1991 357 361
173. K.T. Goh, S.H. Teo, and L. Tay Epidemiology and control of an outbreak of typhoid in a psychiatric institution Epidemiol Infect 108 1992 221 229
174. N. Shinohara, H. Tanaka, and T. Saito Detection of carriers of typhoid bacilli by sewerage-tracing surveillance in Matsuyama City Jpn J Med Sci Biol 34 1981 385 392
175. S.C. Lee, P.H. Yang, and W.B. Shieh Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review Clin Infect Dis 19 1994 693 696
176. W.S. Lee, S.D. Puthucheary, and C.C. Boey Non-typhoid Salmonella gastroenteritis J Paediatr Child Health 34 1998 387 390
177. H.S. Raucher, A.H. Eichenfield, and H.L. Hodes Treatment of Salmonella gastroenteritis in infants: the significance of bacteremia Clin Pediatr (Phila) 22 1983 601 604
178. S. Torrey, G. Fleisher, and D. Jaffe Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis J Pediatr 108 1986 718 721
179. A. Lester, N.H. Eriksen, and H. Nielsen Non-typhoid Salmonella bacteraemia in Greater Copenhagen 1984 to 1988 Eur J Clin Microbiol Infect Dis 10 1991 486 490
180. J.K. Onwubalili Sickle cell disease and infection J Infect 7 1983 2 20
181. C.H. Chiu, T.Y. Lin, and J.T. Ou A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children J Paediatr Child Health 35 1999 372 374
182. S. Sirinavin, and P. Garner Antibiotics for treating salmonella gut infections Cochrane Database Syst Rev 2 2000 CD001167
183. T.D. Tenkate, and R.J. Stafford Risk factors for Campylobacter infection in infants and young children: a matched case-control study Epidemiol Infect 127 2001 399 404
184. A. Horman, R. Rimhanen-Finne, and L. Maunula Campylobacter spp., Giardia spp., Cryptosporidium spp., noroviruses, and indicator organisms in surface water in southwestern Finland, 2000-2001 Appl Environ Microbiol 70 2004 87 95
185. D.N. Taylor, K.T. McDermott, and J.R. Little Campylobacter enteritis from untreated water in the Rocky Mountains Ann Intern Med 99 1983 38 40
186. Centers for Disease Control and Prevention Outbreak of Campylobacter jejuni infections associated with drinking unpasteurized milk procured through a cow-leasing program-Wisconsin, 2001 MMWR Morb Mortal Wkly Rep 51 2002 548 549
187. M. Denis, J. Refregier-Petton, and M.J. Laisney Campylobacter contamination in French chicken production from farm to consumers: use of a PCR assay for detection and identification of Campylobacter jejuni and Camp. coli J Appl Microbiol 91 2001 255 267
188. A. Eyigor, K.A. Dawson, and B.E. Langlois Detection of cytolethal distending toxin activity and cdt genes in Campylobacter spp. isolated from chicken carcasses Appl Environ Microbiol 65 1999 1501 1505
189. W.A. Harrison, C.J. Griffith, and D. Tennant Incidence of Campylobacter and Salmonella isolated from retail chicken and associated packaging in South Wales Lett Appl Microbiol 33 2001 450 454
190. C. Zhao, B. Ge, and J. De Villena Prevalence of Campylobacter spp., Escherichia coli, and Salmonella serovars in retail chicken, turkey, pork, and beef from the Greater Washington, D.C., area Appl Environ Microbiol 67 2001 5431 5436
191. D.N. Taylor, D.M. Perlman, and P.D. Echeverria Campylobacter immunity and quantitative excretion rates in Thai children J Infect Dis 168 1993 754 758
192. S.E. Walz, S. Baqar, and H.J. Beecham Pre-exposure anti-Campylobacter jejuni immunoglobulin A levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand Am J Trop Med Hyg 65 2001 652 656
193. C.A. Whitehouse, P.B. Balbo, and E.C. Pesci Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block Infect Immun 66 1998 1934 1940
194. J.G. Fox, A.B. Rogers, and M.T. Whary Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Campylobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains Infect Immun 72 2004 1116 1125
195. T.E. Hickey, A.L. McVeigh, and D.A. Scott Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells Infect Immun 68 2000 6535 6541
196. J. Okuda, M. Fukumoto, and Y. Takeda Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae Infect Immun 65 1997 428 433
197. D. Purdy, C.M. Buswell, and A.E. Hodgson Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni J Med Microbiol 49 2000 473 479
198. P.H. Everest, H. Goossens, and J.P. Butzler Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli J Med Microbiol 37 1992 319 325
199. R.G. Russell, M. O'Donnoghue, and D.C. Blake Jr Early colonic damage and invasion of Campylobacter jejuni in experimentally challenged infant Macaca mulatta J Infect Dis 168 1993 210 215
200. M.A. Karmali, and P.C. Fleming Campylobacter enteritis Can Med Assoc J 120 1979 1525 1532
201. M.J. Blaser, I.D. Berkowitz, and F.M. LaForce Campylobacter enteritis: clinical and epidemiologic features Ann Intern Med 91 1979 179 185
202. A.A. Drake, M.J. Gilchrist, and J.A. Washington 2nd Diarrhea due to Campylobacter fetus subspecies jejuni: a clinical review of 63 cases Mayo Clin Proc 56 1981 414 423
203. D.J. Farrell, and M.T. Harris A case of intrauterine fetal death associated with maternal Campylobacter coli bacteraemia Aust N Z J Obstet Gynaecol 32 1992 172 174
204. A.E. Simor, and S. Ferro Campylobacter jejuni infection occurring during pregnancy Eur J Clin Microbiol Infect Dis 9 1990 142 144
205. N. McCarthy, and J. Giesecke Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni Am J Epidemiol 153 2001 610 614
206. K.A. Sheikh, T.W. Ho, and I. Nachamkin Molecular mimicry in Guillain-Barre syndrome Ann N Y Acad Sci 845 1998 307 321
207. J.L. Gomez-Garces, R. Cogollos, and J.L. Alos Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents Antimicrob Agents Chemother 39 1995 542 544
208. P.S. Mead, L. Slutsker, and V. Dietz Food-related illness and death in the United States Emerg Infect Dis 5 1999 607 625
209. N.J. Ashbolt Microbial contamination of drinking water and disease outcomes in developing regions Toxicology 198 2004 229 238
210. W.A. Khan, M. Begum, and M.A. Salam Comparative trial of five antimicrobial compounds in the treatment of cholera in adults Trans R Soc Trop Med Hyg 89 1995 1722 1727
211. W.A. Khan, D. Saha, and A. Rahman Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial Lancet 360 2002 103 106